Cargando…

A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic

The purpose of this study was to assess the feasibility and clinical impact of telemedicine-based opioid treatment with buprenorphine-naloxone following the Coronavirus disease 2019 pandemic. METHODS: Participants included in this retrospective analysis consisted of adult New York City residents wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tofighi, Babak, McNeely, Jennifer, Walzer, Dalia, Fansiwala, Kush, Demner, Adam, Chaudhury, Chloe S., Subudhi, Ipsita, Schatz, Daniel, Reed, Timothy, Krawczyk, Noa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339146/ https://www.ncbi.nlm.nih.gov/pubmed/33560696 http://dx.doi.org/10.1097/ADM.0000000000000809

Ejemplares similares

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19
por: Samuels, Elizabeth A., et al.
Publicado: (2022)

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
por: Jakubowski, Andrea, et al.
Publicado: (2022)

Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
por: Bhatraju, Elenore Patterson, et al.
Publicado: (2017)

Telemedicine experience of NYC Internal Medicine residents during COVID-19 pandemic
por: Chiu, Chia-Yu, et al.
Publicado: (2021)

Advancing emergency department–initiated buprenorphine
por: Huntley, Kristen, et al.
Publicado: (2021)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Vital signs assessed in initial clinical encounters predict COVID-19 mortality in an NYC hospital system
por: Rechtman, Elza, et al.
Publicado: (2020)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

Acute Kidney Injury Presenting as Hepatorenal Syndrome in the Setting of Glecaprevir/Pibrentasvir Treatment for Hepatitis C
por: Fansiwala, Kush, et al.
Publicado: (2021)

The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015)

Emergency department‐initiated buprenorphine protocols: A national evaluation
por: Guo, Clara Z., et al.
Publicado: (2021)

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions
por: Kelly, Timothy D., et al.
Publicado: (2022)

Household Food Security and Consumption of Sugar-Sweetened Beverages among New York City (NYC) Children: A Cross-Sectional Analysis of 2017 NYC Kids’ Data
por: Flórez, Karen R., et al.
Publicado: (2023)

Criminal charges prior to and after initiation of office-based buprenorphine treatment
por: Harris, Elizabeth E, et al.
Publicado: (2012)

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
por: Hawk, Kathryn F., et al.
Publicado: (2020)

Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
por: Nguyen, Andrea, et al.
Publicado: (2023)

Prevalence and predictors of suicidality among adults initiating office-based buprenorphine
por: Lent, Michelle R., et al.
Publicado: (2023)

Legislation: NYC Adopts Pesticide Laws
por: Claudio, Luz
Publicado: (2005)

NYC FITNESSGRAM: Population-Level Physical Fitness Surveillance for New York City Youth
por: Day, Sophia E, et al.
Publicado: (2022)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

18 The Impact And Efficiency Of Medical Screening Exams In Forward Treatment Areas At NYC Public Hospitals During The Initial COVID-19 Surge
por: Dilip, M., et al.
Publicado: (2021)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
por: Mattocks, Kristin M., et al.
Publicado: (2022)

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
por: Lambdin, Barrot H., et al.
Publicado: (2022)

Prior criminal charges and outcomes among individuals initiating office-based buprenorphine treatment
por: Harris, Elizabeth E, et al.
Publicado: (2013)

Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study
por: Dong, Kathryn A., et al.
Publicado: (2021)

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
por: Clemency, Brian M., et al.
Publicado: (2022)

Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review
por: Spreen, Lauren A., et al.
Publicado: (2022)

A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
por: Miller, James C., et al.
Publicado: (2023)

Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
por: Krawczyk, Noa, et al.
Publicado: (2021)

Disparities in colorectal cancer screening in New York City: An analysis of the 2014 NYC Community Health Survey
por: Rastogi, Neelesh, et al.
Publicado: (2019)

Perspective from the NYC Assistant Commissioner of the Department of Health
por: Sweeney, M. Monica
Publicado: (2011)

EFFECTS OF COVID-19 ON HEART FAILURE ADMISSIONS IN NYC
por: Friedman, Ari, et al.
Publicado: (2021)

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19
por: Davis, Corey S., et al.
Publicado: (2021)

Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
por: Patel, Sadiq Y., et al.
Publicado: (2022)

Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
por: Tofighi, Babak, et al.
Publicado: (2014)

Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S.
por: Krawczyk, Noa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jglamblev5e3ap4imq176npdr9